Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.4.21.4 (trypsin)
 42,187 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The peptide alpha 1(III)-CB9 was prepared and purified from human liver, and its amino acid sequence was determined. Automated Edman degradation of the intact peptide and peptides derived from selective cleavage with hydroxylamine and digestions with trypsin, thermolysin, and Staph V8 protease enabled determination of the complete amino acid sequence. The peptide alpha 1(III)-CB9 represents the COOH terminus of the helical (pepsin-resistant) portion of type III collagen and terminates in a Cys-Cys sequence responsible for the intramolecular disulfide cross-linkages with other chains. The present work completes the entire amino acid sequence of the helical (pepsin-resistant) portion of human cirrhotic liver type III collagen consisting of peptides alpha 1-(III)-CB3-7-6-1-8-10-2-4-5-9. The COOH terminus of human liver alpha 1(III) contained two additional triplets which, together with the extra triplet at the NH2 terminus in alpha 1(III)-CB3, make the helical portion of type III collagen longer than alpha 1(I) by nine residues (three Gly-X-Y triplets). The helical region of human liver type III collagen, therefore, consists of 1023 amino acids or 341 triplets.
 ...
PMID:Covalent structure of collagen: amino acid sequence of alpha 1(III)-CB9 from type III collagen of human liver. 701 80

This review deals with some structural features of the collagen molecules involved in the adhesion of platelets representing the initial step of hemostasis, thrombosis, and (partly) atherosclerosis. The adhesion occurs at the level of a vascular lesion or deendothelialized area, whatever the genetic type of collagen. In vitro experiments with purified collagens have shown that vascular interstitial collagens (types I and III, the latter present in subendothelium) as well as basement membrane-derived collagens (types IV and V) induce an adhesion of platelets, provided that an ordered arrangement linked to the quaternary and tertiary structures of their molecule is preserved. Whatever the quaternary structure, the important point seems to be the size of the fibers and more precisely the availability of an optimal number of adhesion sites on multimerized fibers. Various direct or indirect proofs (for example, the occurrence of the impairment of collagen multimerization on platelet adhesion/aggregation) are reviewed. Our recent studies on interstitial collagens have shown the involvement of certain specific amino-acid sequences obtained after cyanogen bromide cleavage of collagen. These are the C-terminal alpha1 (I) CB6 peptide of the alpha 1 chains of type I collagen (216 amino acids) and the central alpha1 (III) CB4 peptide from type III collagen (149 amino acids) Cleavage of this last peptide by chymotrypsin, hydroxylamine, and trypsin has suggested the possibility that a nonapeptide (sequence gly-lys-hyp-gly-glu-hyp-gly-pro-lys) is a minimum site of adhesion for platelets. This assumption has been reinforced by the fact that a synthetic nonapeptide with this sequence specifically inhibits the aggregation of platelets to collagen in vitro. The adhesion of platelets may consequently be due to the repetitive staggering of short amino acid sequences (such as this nonapeptide from type III collagen) along the rigid structure formed by a multimerized collagen fiber.
 ...
PMID:[The adhesion of blood platelets to collagen: molecular features of collagen (author's transl)]. 702 81

The proteinaceous coat associated with the cytoplasmic side of milk lipid globule membranes (MLGM) was prepared from bovine and caprine milk by removal of membrane material with non-ionic detergent. These coat preparations, which were enriched in two major proteins, a glycoprotein of polypeptide M, 67 000 (butyrophilin) and a non-glycosylated protein of polypeptide Mr 155 000 (xanthine oxidase), contained small amounts of fatty acids which could not be removed by exhaustive extractions with organic solvents. Both butyrophilin and xanthine oxidase of bovine MLGM were excised and eluted from SDS-polyacrylamide gels and were shown to contain 1 to 2 moles of bound fatty acids per mole of protein. Palmitic, stearic and oleic acids were the predominant protein-bound fatty acids, but no specificity for binding of individual fatty acids was observed. The fatty acids were not rendered soluble in organic solvents when the protein preparations were incubated with phospholipases A or C or with trypsin. Treatment with 0.25 M NaOH at 100 degrees C for 1 h or with 1 M hydroxylamine at 4 degrees C for 16 h, however, released virtually all of the fatty acids associated with these proteins. Similar results were obtained with two major proteins, bands 3 and 4.1, or rat erythrocyte plasma membrane. By contrast, skeletal muscle actin and serum albumin had no bound fatty acids that could be released by alkali treatment. These results show that fatty acids are bound to a number of membrane-associated proteins, both glycosylated and unglycosylated, via linkages that resist purification of the proteins on SDS-polyacrylamide gel electrophoresis and are suggestive of covalent attachment of fatty acids to these proteins. The possible involvement of this acylation in processes characterized by local changes of membrane shape and plasticity is discussed.
 ...
PMID:Tight attachment of fatty acids to proteins associated with milk lipid globule membrane. 706 4

The detailed proof of the 437-residue amino acid sequence (Mr 48,969) of porcine heart citrate synthase (EC 4.13.7) is described. The S-carboxymethylated protein has been cleaved at methionine (cyanogen bromide) and arginine (trypsin digest of citraconylated enzyme) residues to yield 14 and 17 major peptides, respectively. Peptides were initially fractionated by gel filtration, and those useful for sequence analysis were purified by high-performance liquid chromatography. Sequence analyses were performed on these primary peptides and on subpeptides generated by cleavage with the bromine adduct of 2-[(2-nitrophenyl)sulfenyl]-3-methylindole, Staphylococcus aureus V8 protease, trypsin, chymotrypsin, or acid. The overall sequence was confirmed by analyzing products of cleavage by hydroxylamine, acid, and subtilisin. A novel feature of the sequence is the identification of trimethyllysine at residue 368.
 ...
PMID:Complete amino acid sequence of porcine heart citrate synthase. 709 27

The rigor complex of actin and trypsin-treated myosin subfragment 1 (S1) whose heavy chain was cleaved into three fragments (20K, 25K, and 50K) was cross-linked with a zero-length cross-linker, 1-ethyl-3-[3-(dimethyl-amino) propyl]carbodiimide. The cross-linking reaction generated three types of cross-linked products with apparent molecular weights of 65K, 68K, and 95K. The 65K, 68K, and 95K products were covalently linked complexes of actin-20K fragment of the S1 heavy chain, actin-alkaline light chain 1, and actin-50K fragment of the S1 heavy chain, respectively. Cross-linking sites of S1 heavy and light chains on the actin sequence have been determined by digesting the cross-linked products with cyanogen bromide or with hydroxylamine and then mapping resulting peptides on sodium dodecyl sulfate gels. The result indicates that some of the N-terminal acidic residues of actin at positions 1, 2, 3, 4, and 11 are cross-linking sites of the 20K and 50K fragments of the S1 heavy chain while some of its C-terminal acidic residues at positions 360, 362, and 363 are cross-linking sites of the alkaline light chain 1.
 ...
PMID:Identification of myosin-binding sites on the actin sequence. 711 91

Myosin subfragment 1 (S1) was covalently labeled with a fluorescent dye, N-[7-(dimethylamino)-4-methyl-3-coumarinyl]maleimide (DACM), and then digested by trypsin to cleave S1 heavy chain into fragments. The DACM-labeled and trypsin-treated S1 was complexed with F-actin and treated with a zero-length cross-linker, 1-ethyl-3[3-(dimethylamino)propyl] carbodiimide (EDC). The cross-linking reaction generated a covalently linked complex of actin and the 20K fragment of S1 heavy chain, which exclusively incorporated the fluorescent dye, to form a fluorescent 65K cross-linked product. The 20K and 65K fluorescent peptides were isolated and purified and then subjected to cyanogen bromide and/or hydroxylamine cleavages. Mapping of fluorescent cleavage products on acrylamide gels revealed that the N-terminal 20 residues of the 20K fragment of S1 heavy chain contained a cross-linking site of actin.
 ...
PMID:An actin-binding site on the 20K fragment of myosin subfragment 1. 713 30

Pyridoxal 5-phosphate (PLP) treated rat liver triamcinolone acetonide complex was trypsin-digested followed by hydroxylamine treatment. This complex displayed a considerable fraction of DNA binding capacity of the intact complex, which was lost if trypsin digestion had not been preceded by PLP treatment. At the same time trypsin reduced the size of the complex regardless PLP pretreatment. These findings reveal that DNA binding does not require a large complex.
 ...
PMID:Pyridoxal 5-phosphate protection of trypsin cleavage site on the glucocorticoid receptor protein. 717 55

Two reactive SH groups (SH1 and SH2) of myosin subfragment 1 (S-1) were selectively labeled with a fluorescent dye, N-[7-(dimethylamino)-4-methyl-3-coumarinyl]maleimide (DACM). When the DACM-S-1 was digested with trypsin, 95K heavy chain was cleaved into 50K, 25K, and 20K fragments, and the fluorescent labels incorporated into SH1 and SH2 were exclusively found in the 20K fragment, indicating that these SH groups were located in the fragment. When the trypsin-treated DACM-S-1 was subsequently fragmented with hydroxylamine in 6 M guanidine hydrochloride at pH 9.0, the fluorescent 20K fragment was cleaved into two fluorescent segments, the 13K segment containing SH1 and the 5K segment containing SH2. Since it is known that SH1 and SH2 are only 10 residues apart in the sequence and that SH1 is nearer the COOH terminus than SH2, the results show that these reactive SH groups are separated from the COOH terminus of S-1 heavy chain by a 13K-dalton stretch of polypeptide chain.
 ...
PMID:Location of SH1 and SH2 along a heavy chain of myosin subfragment 1. 724 83

1. RNase St was inactivated by iodoacetate. The inactivation was most rapid at pH 5.0-7.0. Competitive inhibitors protected RNase St from inactivation by iodoacetate. The protective effect of 2'-GMP was most effective among nucleotides tested. 2. RNase St was inactivated with the concomitant incorporation of one molar equivalent of carboxymethyl group. The carboxymethyl group incorporated into RNase St was liberated by treatment with 0.2 N NaOH or 1 M hydroxylamine. Thus the incorporation of a carboxymethyl group into a carboxyl group was demonstrated. 3. 14C-labeled CM-RNase St was digested successively with alkaline protease and aminopeptidase M. The 14C-labeled amino acid was identified as the carboxymethyl ester of glutamic acid by means of column chromatography. 4. By digestion of reduced carboxymethylated CM-RNase St with trypsin, a peptide containing a 14C-carboxymethyl group was isolated by Dowex AG-50W colum chromatography. alpha-Chymotryptic digestion of the radioactive tryptic peptide, Glu48-Lys65, produced a tetrapeptide containing a 14C-carboxymethyl group, that is, Tyr59-His60-Glu61-Tyr62. Therefore, it was concluded that Glu61 in RNase St was the site of carboxymethylation. 5. When RNase St was inactivated by iodoacetamide at pH 8.0, about 2 histidine residues were modified. The molar ratio of the products of carboxyamidomethylation were 52.3%, 21.7%, 21.0%, and 4.8% for 3-CAM-His, 1,3-di-CAM-His, 1-CAM-His, and di-CM-Lys, respectively. 6. CD spectra of CM-RNase St and CAM-RNase St were practically the same as that of the native RNase St indicating the maintenance of the native conformation during modification. 7. The binding constants of CM-RNase St and CAM-RNase St with 2'-GMP were about 1/150 and 1/38 of that of the native enzyme, respectively.
 ...
PMID:Alkylation of a ribonuclease from Streptomyces erythreus with iodoacetate and iodoacetamide. 728 72

Treatment of human C3 with hydroxylamine or hydrazine at physiological pH and ionic strength totally abrogates the intrinsic ability of this protein to sustain classical pathway induced hemolysis of sheep red blood cells. Concomitant with the loss of this function the appearance of a single sulfhydryl group can be followed by titration with the sulfhydryl-specific reagents p-(chloromercuri)benzoate, [1-14C]iodoacetamide, 2,2'-dipyridyl disulfide, and 5,5'-dithiobis(2-nitrobenzoic acid). These reagents have also been used to follow the appearance of a free sulfhydryl group on conversion of C3 to C3b with bovine trypsin. Autoradiography of the electrophoretogram of separated alpha-, alpha'-, and beta-polypeptide chains of inactivated, [1-14C]carboxamidomethylated C3 samples has shown that the reactive sulfhydryl group is present in the alpha chain of C3 and in the alpha' chain of C3b, respectively. Digestion of the radiolabeled protein with porcine elastase has localized this sulfhydryl group to a 28 000-dalton fragment of the alpha chain with immunochemical and functional reactivities of the C3d domain. Autoradiographic analysis of a hydrolysate prepared from radioalkylated C3 and subjected to high-voltage paper electrophoresis has shown the labeled amino acid to be [1-14C]-S-(carboxymethyl)cysteine. The susceptibility of native C3 to rapid and irreversible inactivation by nitrogen nucleophiles with the parallel appearance of a cysteinyl residue may indicate the presence of an internal thiol ester. The relationship of the proposed thiol ester to the ability of nascent C3b to acylate cell surface components and carbohydrate polymers is discussed within the context of a transesterification reaction.
 ...
PMID:Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation. 740 85


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>